General Information of Drug (ID: DMT6IYM)

Drug Name
MGTA-456
Indication
Disease Entry ICD 11 Status REF
Metabolic disorder 5C50-5D2Z Phase 2 [1]
Drug Type
Cell therapy
Cross-matching ID
TTD ID
D14SKB

References

1 ClinicalTrials.gov (NCT03406962) MGTA-456 in Patients With Inherited Metabolic Disorders Undergoing Hematopoietic Stem Cell Transplantation (HSCT). U.S. National Institutes of Health.